NCT07391761Active, not recruiting
A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan
A Multi-center Observational Study of the Effectiveness of Elranatamab in Patients With Relapsed and/or Refractory Multiple Myeloma in Taiwan
Source: ClinicalTrials.gov · Last updated 1 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate: * What is the real-world effectiveness of elranatamab in patients with relapsed and/or refractory multiple myeloma (RRMM) in Taiwan? * What are the baseline and clinical characteristics of RRMM patients who have received eltanatamab in Taiwan? * What are the treatment patterns of RRMM patients receiving elranatamab in the real-world setting in Taiwan?
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1 (estimated)
- First submitted
- 15 Dec 2025
- Start date
- 11 May 2026
- Primary completion date
- 31 Jan 2028
- Lead sponsor
- Pfizer
- Diseases
- Multiple myeloma
- NCT number
- NCT07391761
What you commit to
- Study type: Observational
- Planned participants: 1
- From 11 May 2026 to the primary completion date, 31 Jan 2028
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who participated in any prior clinical trials using elranatamab.
Who the study is looking for
- Patients age ≥ 18 years at the initiation of elranatamab
- Patients who have received at least one dose of elranatamab in consistent with the approved label in Taiwan.
- Evidence of a personally signed and dated informed consent document (ICD) indicating that the patient (or a legally acceptable representative) has been informed of all pertinent aspects of the study. The ICD waiver is acceptable for patient who was ceased before recruitment.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kaohsiung Chang Gung Memorial Hospital Coordinator of this site? Confirm its status | Kachsiung | Taiwan | Unknown status |
| Taichung Veterans General Hospital Coordinator of this site? Confirm its status | Taichung | Taiwan | Unknown status |
| Taipei Veterans General Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
| Linkou Chang Gung Memorial Hospital Coordinator of this site? Confirm its status | Taoyuan | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.